skip to Main Content

Scientists Identify Drug Target That Could Lead to Development of New Cancer Therapies

Scientists Identify Drug Target That Could Lead to Development of New Cancer Therapies
Scientists have identified a protein that could lead cancer therapies for aggressive cancers.

Researchers from The Tisch Cancer Institute at Mount Sinai Icahn School of Medicine in New York identified a protein that may be an unexplored target to develop new cancer therapies.

The protein is called kinase suppressor of Ras or KSR, is a pseudoenzyme that plays an important role in the transmission of signals in the cell, which helps determine whether cells grow, divide or die, the researchers said in a press release. According to the scientists, targeting this protein could lead to improved therapeutic outcomes in cancers, such as lung and pancreatic cancers. Read more . . .


Back To Top